Indications and uses
• relieves heartburn associated with acid indigestion and sour stomach • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
• relieves heartburn associated with acid indigestion and sour stomach • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
• adults and children 12 years and over: • to relieve symptoms, swallow 1 tablet with a glass of water • to prevent symptoms, swallow 1 tablet with a glass of water right before or any time up to 30 minutes before eating food or drinking beverages that cause heartburn • do not take more than 2 tablets in 24 hours • children under 12 years: ask a doctor
• do not use if printed foil under cap is broken or missing • store at 20°-25°C (68°-77°F)
Cimetidine 200 mg
Acid reducer
Allergy alert: Do not use if you are allergic to cimetidine or other acid reducers
taking
If you are not sure you are taking one of these medicines, talk to your doctor or pharmacist.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, povidone, pregelatinized starch, sodium lauryl sulfate, sodium starch glycolate, titanium dioxide
1-800-719-9260
Cimetidine Tablets, 200 mg
Acid Reducer
For Heartburn
Just one Cimetidine Tablet, 200 mg relieves and prevents heartburn and acid indigestion.
This product reduces the production of stomach acid that can cause heartburn.
In clinical studies, Cimetidine Tablets, 200 mg was significantly better than placebo tablets in relieving and preventing heartburn symptoms.
And Cimetidine Tablets, 200 mg is approved to take before, during, or after a meal.
Percent of Heartburn Episodes Relieved

Percent of Patients with Prevention or Reduction of Heartburn Symptoms When Taken 30 Minutes Before a Meal

Percent of Patients with Prevention or Reduction of Heartburn Symptoms When Taken at Time of Meal

Drug Interaction Warnings:
This product affects some prescription medicines causing slightly higher levels of those medicines in the blood. Higher blood levels could lead to side effects in rare situations. If you currently take Theophylline (oral asthma medicine), Warfarin (blood thinning medicine) or Phenytoin (seizure medicine), consult your doctor before taking this product.
Brand names of some medicines which contain one of these ingredients include:
THEOPHYLLINE | THEO-DUR® Theochron® Slo-Bid® Uniphyl® Theo-24® |
WARFARIN | Coumadin® |
PHENYTOIN | Dilantin® |
There may be other medicines that contain one of these ingredients. If in doubt about this or about possible effects of this product on any other medicines you are taking, talk to your doctor or pharmacist.
For Prevention and Relief of Heartburn
Tips for Managing Heartburn
READ THE LABEL
Read the directions and warnings before taking this medication.
Questions or comments? 1-800-719-9260
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-4203-1 | 2021-09-10 | C162847 | 48780-1 | 9855d018-de83-cd31-e053-dbdaa90ab51a | Perrigo Heartburn Relief Drug Facts |
| 63629-4203-2 | 2021-09-10 | C162847 | 48780-1 | 9855d018-de83-cd31-e053-dbdaa90ab51a | Perrigo Heartburn Relief Drug Facts |
| 63629-4203-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-de83-cd31-e053-dbdaa90ab51a | Perrigo Heartburn Relief Drug Facts |
| 63629-4203-2 | 2019-11-27 | C162847 | 48780-1 | 9855d018-de83-cd31-e053-dbdaa90ab51a | Perrigo Heartburn Relief Drug Facts |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0113-0022-39 | EA - Each | 0113-0022 | 250cf7c6-fd71-492a-94e8-ed110c3d528a | 1 | 2017-12-14 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CIMETIDINE | ACTIVE INGREDIENT | 80061L1WGD | 1000 | |
| CIMETIDINE | ACTIVE MOIETY | 80061L1WGD | 1000 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1000 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1000 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1000 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1000 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1000 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | 1000 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 1000 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1000 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63629-4203 | 63629-4203-1, 63629-4203-2 |
| 0113-0022 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CIMETIDINE | 80061L1WGD | ACTIB |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POLYETHYLENE GLYCOLS | 3WJQ0SDW1A | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| POVIDONES | FZ989GH94E | IACT |
| SODIUM LAURYL SULFATE | 368GB5141J | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRASYNOVIAL | 4 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | CAPSULE, COATED PELLETS / ORAL | 10.03 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SPRAY, METERED / NASAL | 0.1 mg/1ml | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | SOLUTION / ORAL | 3000 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / OPHTHALMIC | 1 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | DROPS / AURICULAR (OTIC) | 0.02 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 4739 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SYSTEM / TOPICAL | 420 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET, EXTENDED RELEASE / ORAL | 101 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | DROPS / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | OINTMENT / TOPICAL | 14 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, DELAYED RELEASE / ORAL | 4 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CREAM / TOPICAL | 20 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, COATED / ORAL | 123 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRAVITREAL | 0.02 %w/v | ||
| POVIDONES | POVIDONE | FZ989GH94E | SUSPENSION / AURICULAR (OTIC) | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, ORALLY DISINTEGRATING / ORAL | 16 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | GRANULE, FOR SUSPENSION / ORAL | 240 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CREAM / VAGINAL | 12 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 42 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | INJECTION / INTRAMUSCULAR | 0.2 %w/v | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | SUSPENSION / ORAL | 20 mg/5ml | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET, COATED / ORAL | 49.2 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, COATED PELLETS / ORAL | 2 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | SOLUTION / OPHTHALMIC | 1.8 %w/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | PASTE / ORAL | 28 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, CHEWABLE / ORAL | 6 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | GRANULE / ORAL | 12 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, EXTENDED RELEASE / ORAL | 10 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | POWDER, FOR SUSPENSION / ORAL | 396 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | SHAMPOO, SUSPENSION / TOPICAL | 40 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, EFFERVESCENT / ORAL | 1.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAMUSCULAR | 4 %w/v | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | PASTE, DENTIFRICE / DENTAL | 1.4 %w/w |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075285-001 | CIMETIDINE | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A075285-001 | CIMETIDINE | 200MG | TABLET / ORAL | 1998-10-29 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3f80b20b-2059-4db5-8633-0bde90608a8e | c7a91800-4078-4e12-8e0c-7379f88ec41b | 2021-08-17 | Warnings | c7a91800-4078-4e12-8e0c-7379f88ec41b |
Adverse event summaries are temporarily unavailable. Other product information remains available.